Welcome to Sysmex Inostics

Empowering discoveries in oncology

We provide ultra-sensitive liquid biopsy solutions for exceptional ctDNA detection. We partner with BioPharma companies to aid cancer drug and diagnostic development to monitor therapy response, identify targetable resistance, and detect minimal residual disease (MRD).

Our Approach

No molecule left behind

We are devoted to ultra-sensitive and accurate detection of ctDNA from a simple blood draw. Focused and flexible genomic coverage can expedite oncology studies and provide deeper insights into patient response to new therapies. Our technology is optimized to ensure low-frequency mutant molecule detection with high specificity and efficiency.

Learn more about Sysmex Inostics

Approach

Our Products & Solutions

Sensitive and specific liquid biopsy

About Us

On a mission to help defeat cancer

We’re pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection. With more than 10 years of partnership experience with leading BioPharma companies, we offer expert-developed Plasma-Safe-SeqS (NGS) and OncoBEAM™ (digital PCR) technologies and cost-effective assays from our CLIA-certified lab.
Read more about our technology

News & Events

The latest

Visit our resource center

Visit our resource center